T2 Biosystems Long Term 2023 Target $22

NASDAQ:TTOO   T2 Biosystems, Inc.
T2 Biosystems Revenue for Q3 2021 was exceptionally good.
Expecting $5.48 by end of 2021/Q1-2022, followed by $22 by 2023 long term.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.